Quest Diagnostics and Tower Health are teaming up to enhance the quality and value of diagnostic services to patients and their doctors. Under the multi-year agreement Quest will provide laboratory supply chain expertise, including the purchase of capital equipment, supplies and reagents. Quest will also continue to perform reference testing for Tower, in addition to further exploring additional opportunities that drive long-term value for both organizations.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on DGX:
- Quest Diagnostics to acquire select assets of NYP laboratory services business
- Quest Diagnostics and NewYork-Presbyterian Agree to Laboratory Services Transaction
- Quest Diagnostics raises quarterly dividend, increases share repurchase program
- Quest Diagnostics sees FY23 adjusted EPS $8.40-$9.00, consensus $8.69
- Quest Diagnostics reports Q4 adjusted EPS $1.98, consensus $1.91